HIGHLIGHTS
- who: Niamh Coleman from the Published in partnership with The Hormel Institute, University of Minnesota have published the paper: Antibody-drug conjugates in lung cancer: dawn of a new era?, in the Journal: (JOURNAL) of August/11,/2022
- what: In this review, the authors discuss the structure and mechanism of action of ADCs, including insights from pre-clinical work; the authors explore the activity in lung cancer and summarize the recent progress of ADCs in the clinic , describe current challenges and toxicity profiles of these compounds; finally, the authors explore potential combination strategies and other . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.